With CTLA-4, symptoms typically start manifesting within 5 to 8 weeks, whereas with anti-PD-1 or PD-L1 treatment, colitis typically occurs 3 to 6 months after initiating treatment [7,10,20]. Here, CD274 is linked to colitis.